This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Vraylar 3 mg capsules, a specialty medication, with a ceiling value of $6,364.96. The contract is a firm fixed price delivery order with an ultimate completion date of October 18, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,051.83, is for the delivery of Vraylar 1.5 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vraylar 3 mg capsules, a medication used to treat certain mental health conditions. The award has a ceiling value of $5,920.16 and an ultimate completion date of June 7, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $12,757.66. The contract is for the supply of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,234.75, is for the provision of Vraylar 1.5 mg capsules. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Vraylar 3 mg capsules. The firm-fixed-price contract has a ceiling value of $7,614.22 and a period of performance through November 27, 2024. This order is placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Vraylar 1.5 mg capsules to support military treatment programs and facilities. The contract has a ceiling value of $15,999.35 and a performance period through March 14, 2024. Amerisourcebergen Drug Corp also holds an Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,038.68 firm fixed-price contract is for the supply of Vraylar 3 mg capsules and is not designated as a set-aside. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $2,656.83 and has an ultimate completion date of March 26, 2024. It is not designated as a set-aside contract. The contract provides for the delivery of Vraylar 6 mg capsules, a prescription medication used to treat certain mental health conditions. As an Indefinite Delivery Contract (IDC) holder with the...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Vraylar 4.5 mg capsules to support military treatment programs and facilities. The contract has a ceiling value of $10,486.16 and a period of performance through April 9, 2024. No set-aside designation was used for this...